No Detail Found!

The Impact of Cytokine Storms on Severe Infectious Diseases Progression: A Narrative Review

Author(s)
Roksolana Yaremkevych Department of Surgery and Transplantology, Faculty of Postgraduate Education, Danylo Halytsky Lviv National Medical University, Lviv, Ukraine
Nataliia Bodnarchuk-Sokhatska Department of Pediatric, Faculty of Foreign Students, Horbachevsky Ternopil National Medical University, Ternopil, Ukraine
Serhii Sydorov DVM, Department of Forest Biology, Hunting Science and Ichthyology, Zaporizhzhia National University, Zaporizhzhia, Ukarine
Yuliia Kyivska Private Entrepreneur, Kharkiv, Ukraine
He GangKui Dazhou Second People's Hospital, Sichuan, China
Abstract
Background: Cytokine storm is a life-threatening immune reaction contributing to the severity of various infectious diseases such as COVID-19, sepsis, Ebola, and Dengue. Understanding its pathophysiology is critical for timely diagnosis and effective treatment. Methods: A narrative review was conducted using PubMed, Scopus, and Web of Science (September 2024 - January 2025). Keywords included “cytokine storm,” “pro-inflammatory cytokines,” “COVID-19,” “sepsis,” “targeted therapy,” and “personalised medicine.” Studies were analysed thematically. As a narrative review, the findings are limited by the heterogeneity and potential bias of included studies, and no quantitative synthesis was performed. Results: The review outlines key mechanisms of cytokine storm, such as IL-6, IL-10, and TNF-a overproduction, and presents clinical cutoff values (e.g., IL-6 > 19.5 pg/mL) associated with disease severity. Targeted therapies (e.g., tocilizumab, anakinra), immunomodulators (e.g., JAK inhibitors), stem cell therapy, and plasmapheresis were reviewed. A personalised approach to treatment based on biomarkers and comorbidities was emphasised. Conclusions: Cytokine storm remains a major challenge in infectious disease management. While therapeutic strategies are evolving, individualised, biomarker-driven treatment offers the greatest potential for improving outcomes.
Publication Details
Page(s) 89-97
Published Journal: Journal of Pioneering Medical Sciences, Volume: 14, Issue: 4, Year: 2025

Request the full text from PASTIC

Keywords
relaxation techniques, Mental health, Stress, Stress Management, Distress, cognitive restructuring, eustress, mindfulness meditation, Sudarshan Kriya, Pranayama
References
Karki ,Thirumala-Devi Kanneganti . .The 'cytokine storm': molecular mechanisms and therapeutic prospects.” Trends in immunology. , 4906(21) : 00115-0.
Shen ,Junyi .2024 .Frontiers and hotspots evolution in cytokine storm: A bibliometric analysis from 2004 to 2022. , 8440(24) : 06986-X.
.2024 .. [3] World Health Organization Global report on infection prevention and control 2024: executive summary, : .
Gebreyohannes Eyob,Alemayehu Eyob .2024 .Impacts of armed conflicts on tuberculosis burden and treatment outcomes: a systematic review. ” BMJ Open, 14(3) : .
2021 Forecasting Collaborators GBD .2025 .-2050: a forecasting analysis for the Global. Burden of Disease Study 2021.” Lancet, 403(10440) : 2204-2256.
Berbudi ,Afiat . .Type 2 diabetes and its impact on the immune system. ” Current Diabetes Reviews, 16(5) : 442-449.
Melo . .Biomarkers of cytokine storm as red flags for severe and fatal COVID-19 cases: A living systematic review and meta-analysis.” PloS one. , 0253894(6) : .
van Meijgaarden,Krista E. Meijgaarden . .Longitudinal soluble marker profiles reveal strong association between cytokine storms resulting from macrophage activation and disease severity. in COVID-19 disease.” Scientific Reports, 14(1) : .
Meggyes ,Matyas .2024 .Can there be calm during a cytokine storm? Immune checkpoint pathways affecting the severity of COVID-19 disease. , 15 : .
Chousterman Benjamin G. .2017 .Cytokine storm and sepsis disease pathogenesis.” Seminars in immunopathology. , 39 : 517-528.
Turgutkaya ,Atakan ,July .2020 .Application of plasmapheresis for Covid‐19 patients. Therapeutic Apheresis and Dialysis, 25(2) : .
Sadeghi ,Alireza .2023 .Efficacy of plasmapheresis in neutropenic patients suffering from cytokine storm because of severe COVID-19 infection. Blood research, 58(2) : 91-98.
Patel ,Jatin .2023 .A randomised trial of anti-GM-CSF otilimab in severe COVID-19 pneumonia (OSCAR). ” European Respiratory Journal, 61(2) : 29.
Shi ,Yingying ,November .2024 .Progress and prospects of mRNAbased drugs in pre-clinical and clinical applications. ” Signal Transduction and Targeted Therapy, 9(1) : .
0

Citations

0

Downloads

64

Views